Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

Trump accuses FDA of delaying Pfizer’s COVID-19 vaccine announcement 

By Brian Buntz | November 13, 2020

Donald Trump

President Donald Trump [Image courtesy of White House]

In the aftermath of Pfizer’s (NYSE: PFE) announcement that its COVID-19 vaccine promises to be 90% effective, President Trump is faulting the FDA for its role allegedly delaying the announcement until after Election Day. The President has pointed to the episode as evidence for a ‘medical deep state,” according to the Washington Post.

Already, HHS Secretary Alex Azar had reportedly discussed the prospect of removing Dr. Stephen Hahn as FDA commissioner.

Now, Trump has requested that Azar “get to the bottom” why the Pfizer announcement came after Election Day, according to a Washington Post article citing an anonymous source. After the Pfizer announcement, Trump reportedly called Hahn “screaming at him,” according to the newspaper.

In a recent coronavirus task force meeting, Hahn said that the timing of the Pfizer announcement was based on the company’s independent decisions alone.

Pfizer CEO Albert Bourla echoed that sentiment in a recent CNN interview, stating that the announcement’s timing was based on scientific rather than political considerations.

Azar, however, argued differently, suggesting that FDA deliberately caused a delay in Pfizer’s announcement.

The timing of Pfizer’s is coincidental, according to the Annenberg Public Policy Center FactCheck.org

Tensions between the White House and the FDA had been building for months, according to Politico.

Tell Us What You Think! Cancel reply

Related Articles Read More >

OncoSec eyes next steps with its cancer immunotherapy candidate
Pharma researcher charged with theft of trade secrets  
Norway investigating deaths of 23 individuals who received COVID-19 vaccine
Pharma image
Here’s what molecular shape can tell you about pharma innovation

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards